Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3

Nature Genetics

Volumn 12, Issue 4, 1996, Pages 390-397

  Colvin, Jennifer S ^a   Bohne, Barbara A ^a   Harding, Gary W ^a   McEwen, Donald G ^a   Ornitz, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ACHONDROPLASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DWARFISM; ENCHONDRAL OSSIFICATION; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HEARING IMPAIRMENT; INNER EAR MALFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACHONDROPLASIA; ANIMALS; BONE DISEASES, DEVELOPMENTAL; DEAFNESS; DNA; EAR, INNER; FEMALE; GENE TARGETING; HOMOZYGOTE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; OSTEOGENESIS; PHENOTYPE; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 0029928791     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0496-390     Document Type: Article

References (38)

1. Basilico, C. & Moscatelli, D. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-165 (1992).
2. Muenke, M. & Schell, U. Fibroblast-growth-factor receptor mutations in human skeletal disorders Trends Genet. 11, 308-313 (1995).
3. Johnson, D.E & Williams, L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41 (1993).
4. Hébert, J M., Rosenquist, T., Gotz, J & Martin, G.R. FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations Cell 78, 1017-1025 (1994).
5. Feldman, B., Poueymirou, W., Papaioannou, V.E., DeChiara, T.M. & Goldfarb, M. Requirement of FGF-4 for postimplantation mouse development Science 267, 246-249 (1995).
6. Peters, K G , Werner, S , Chen, G. & Williams, L.T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114, 233-243 (1992).
7. Peters, K , Omitz, D.M., Werner, S. & Williams, L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155, 423-430 (1993).
8. Rousseau, F et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252-254 (1994).
9. Shiang, R. et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia Cell 78, 335-342 (1994).
10. Tavormina, P.L. et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet. 9, 321-328 (1995).
11. Briner, J , Giedion, A. & Spycher, M.A. Variation of quantitative and qualitative changes of enchondral ossification in heterozygous achondroplasia. Pathol Res Pract 187, 271-278 (1991).
12. Rimoin, D.L., Hughes, G.N., Kaufman, R L., Rosenthal, R.E., McAlister, W.H & Silberberg, R. Endochondral ossification in achondroplastic dwarfism. New Engl. J. Med 283, 728-735 (1970)
13. Meyers, G.A , Orlow, S.J., Munro, I R. & Jabs, E.W Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans Nature Genet. 11, 462-464 (1995).
14. Chellaiah, A T., McEwen, D.G., Werner, S., Xu, J & Ornitz, D.M. Fibroblast growth factor receptor (FGFR) 3: alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J Biol Chem 269, 11620-11627 (1994).
15. Caplan, A.I. & Pechak, D.G The cellular and molecular embryology of bone formation. in Bone and Mineral Research Vol. 5. (ed. Peck, W. A.) 117-183. (Elsevier Science Publishers, New York, 1987).
16. Iannotti, J.P. Growth plate physiology and pathology. Orthop. Clin. North Am 21, 1-17 (1990)
17. Kikuchi, K. & Hilding, D. The development of the organ of Corti in the mouse. Acta. Otolaryngol (Stockh.) 60, 207-222 (1965).
18. Pinelli, V., Masi, R., Partipilo, P , Pierro, V. & Tieri, L Otologic impairments in achondroplasia: a nosologic assessment. In Human Achondroplasia. (ed. Nicoletti, B., Kopits, S.E., Ascani, E. & McKusick, V.A.) 149-152 (Plenum Press, New York & London, 1988).
19. Engstrom, H., Ades, H W. & Andersson, A. Structural pattern of the organ of Corti. (Almqvist & Wiksell, Stockholm, 1966)
20. Mikaelian, D.O , Warfield, D. & Norris, O. Genetic progressive hearing loss in the C57/bl6 mouse. Acta Otolaryngol. 77, 327-334 (1974).
21. Ponseti, I.V. Skeletal growth in achondroplasia. J. Bone Joint Surg. Am. 52-A, 701-716 (1970).
22. Kato, Y. & Iwamoto, M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J. Biol. Chem. 265, 5903-5909 (1990).
23. Baron, J. et al. Induction of growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology 135, 2790-2793 (1994).
24. Pirvola, U et al. The site of action of neuronal acidic fibroblast growth factor is the organ of Corti of the rat cochlea. Proc. Natl. Acad. Sci. USA 92, 9269-9273 (1995).
25. Ernfors, P., Van De Water, T., Loring, J. & Jaenisch, R. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 14, 1153-1164 (1995).
26. Sidman, R.L., Green, M C & Appel, S.H. Catalog of the neurological mutants of the mouse. (Harvard University Press, Cambridge, Massachusetts, 1965).
27. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163 (1991).
28. Chisaka, O & Capecchi, M R. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 350, 473-479 (1991)
29. Shen, M.M. et al. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J. 13, 1375-1385 (1994).
30. Ornitz, D.M. & Leder, P Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267, 16305-16311 (1992).
31. Perez-Castro, A.V., Wilson, J. & Altherr, M R. Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene. Genomics 30, 157-162 (1995).
32. Lufkin, T., Dierich, A., LeMeur, M., Mark, M. & Chambon, P Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression. Cell 66, 1105-1119 (1991).
33. Wallin, J. et al. The role of Pax-1 in axial skeleton development Development 120, 1109-1121 (1994).
34. Bohne, B.A. Location of small cochlear lesions by phase contrast microscopy prior to thin sectioning. Laryngoscope 82, 1-16 (1972).
35. Richardson, K.C , Jarrett, L. & Finke, E.H. Embedding in epoxy resin for ultrathin sectioning for electron microscopy. Stain Tech 35, 313-323 (1960)
36. Henry, K.R. Auditory nerve and brain stem volume-conducted potentials evoked by pure-tone pips in the CBA/J laboratory mouse. Audiology 18, 93-108 (1979).
37. Henry, K.R. & Chole, R A. Cochlear electrical activity in the C57BL/6 laboratory mouse: volume-conducted vertex and round window responses. Acta Otolaryngol. 87, 61-68 (1979).
38. Davis, H. et al. Acoustic trauma in the guinea pig J Acoust. Soc. Am. 25, 1180-1189 (1953).